JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2018. Vol. 63. No. 6. P. 34–40
RADIATION EPIDEMIOLOGY
DOI: 10.12737/article_5c0b8a6f16bcf5.47924988
I.L. Shafransky, A.R. Tukov, A.P. Birukov, I.V. Sidorin, L.A. Potapova, O.N. Prokhorova, Yu.D. Udalov, L.A. Ilyin, A.M. Lyaginskaya, V.Yu. Soloviev
Estimation of the Excess Relative Risk of Malignant Neoplasms among Workers of the Nuclear Industry – Participants of the Accident Liquidation at the Chernobyl NPP
A.I. Burnasyan Federal Medical Biophysical Center, Moscow, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
I.L. Shafransky – Senior Researcher, PhD Med.; A.R. Tukov – Head of Lab., PhD Med.;
A.P. Birukov – Head of Dep., Dr. Sci. Med., Prof.; I.V. Sidorin – Senior Researcher, PhD Phys.-Math.;
L.A. Potapova – Senior Researcher, PhD Med.; O.N. Prokhorova – Engineer-Researcher;
Yu.D. Udalov – Deputy Director General, PhD Med.; L.A. Ilyin – Dr. Sci. Med., Prof., Academician of RAS;
A.M. Lyaginskaya – Сhief Researcher, Dr. Sci. Biol., Prof.; V.Yu. Soloviev – Head of Lab., Dr. Sci. Biol., PhD Tech.
Abstract
Purpose: To assess the excess relative risk in terms of 1 Sv on the basis of materials on the incidence of malignant neoplasms of workers in the nuclear industry – liquidators of the Chernobyl accident, as well as part of workers who worked or continue to work with sources of ionizing radiation.
Material and methods: The data base of the Industry Register of persons exposed to radiation as a result of the Chernobyl accident (ORF) was used in the work. Methods of cohort analysis of the accumulated disease incidence were used, based on Poisson regression and Cox regression. Estimates of the ERR at 1 Sv were calculated using both the traditional scheme using the AMFIT module and the modified formula proposed by Paretzke.
Results: It is shown that in some cases, the risk estimates obtained by the modified formula are more realistic, in other cases both estimates have similar values.
Conclusion: Analysis of the incidence of solid neoplasms in the liquidator cohort showed:
1. At the dose range < 200 mSv, point estimates of relative risk indicate that there is no dose-associated risk.
2. In the low-dose range for risk assessment, a modified Poisson regression approach that is free of control specifics should be used.
3. The validity of a dose response is characterized by the risks obtained using a dose of occupational exposure.
4. An important issue is the calculation of the risk of radiation-caused diseases with the use of the total dose received by an individual from all types of radiation.
Key words: radiation risk, malignant neoplasms, doses of different types of radiation, total dose, Chernobyl accident, liquidators
REFERENCES
- Heidenreich W, Paretzke H, Jacob P. No evidence for increased tumor rates below 200 mSv in the atomic bomb survivors data. Radiat Environ Biophys. 1997;36(3):205-7.
- Shafranskiy IL, Ilin LA, Tukov AR, Rozhdestvenskiy LM. Comparative risk analysis of radiation-induced morbidity of malignant neoplasms of nuclear industry workers-liquidators of the Chernobyl accident and survivors of the atomic bombing – according to the study LSS. Med Radiology and Radiation Safety. 2009;54(2):33-7. (Russian).
- Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Eric J. Studies of Mortality of Atomic Bomb Survivors. Report 14: Solid Cancer and Noncancer Disease Mortality: 1950–1997. Radiat Res. 2009;(177):229-43.
- Preston D, Shimizu Y, Pierce D, Suyama A, Mabuchi K. Studies of Mortality of Atomic Bomb Survivors. Report 13: Solid Cancer and Noncancer Disease Mortality: 1950–1997. Radiat Res. 2003;(160):381-407.
- Koks DR, Ouks D. Analysis of life time type data. Moscow, Finance & statistic. 1988.
- Koryistov YuN. Factors that distort the assessment of carcinogenic risk of low doses of radiation according to epidemiological data. Med Radiology and Radiation Safety. 2014;59(4):41-7. (Russian).
- Petin VG, Pronkevich MD. Analysis of the effect of low doses of ionizing radiation on human cancer. Radiat and risk. 2012;21(1):39-57. (Russian).
- Sakai K. Biological responses to low dose radiation-hormesis and adaptive responses. Yakugaku Zasshi. 2006 Oct;126(10):827-31.
- Gorskiy AI, Maksyutov MA, Tumanov KA, Schukina NV, Chekin SYu, Ivanov VK. Nonparametric analysis of radiation risks of mortality among liquidators of the Chernobyl accident. Radiation Biology. Radioecology. 2016;56(2):138-48. (Russian).
- Obesnyuk VF. The effect of competing streams of events in the cohort risk assessment of radiation-epidemiological studies. Med Radiology and Radiation Safety. 2010;55(6):14-25. (Russian).
- Brenner D, Doll R, Goodhead D, Hall E, Land C, Little J, et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. PNAS. 2003;100(24):13761-6.
For citation: Shafransky IL, Tukov AR, Birukov AP, Sidorin IV, Potapova LA, Prokhorova ON, Udalov YuD, Ilyin LA, Lyaginskaya AM, Soloviev VYu. Estimation of the Excess Relative Risk of Malignant Neoplasms among Workers of the Nuclear Industry – Participants of the Accident Liquidation at the Chernobyl NPP. Medical Radiology and Radiation Safety. 2018;63(6):34-40. (Russian).